4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-21-000004
President and CEO sold 19,026 shares at $106.01 ($2,016,901)
- President and CEO acquired 19,026 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kramer Robert President and CEO | 2021-01-15 | Option exercise | +19,026 | $25.62 | $487,446 | 158,236 | D: show line 1 in the form |
| Kramer Robert President and CEO | 2021-01-15 | Sale | −19,026 | $106.01 | $2,016,901 | 139,210 | D: show line 2 in the form |
| Open-market sales · 19,026 sh · avg $106.01 · $2,016,901 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kramer Robert President and CEO | 2021-01-15 | Option exercise · Employee Stock Options (Right to Buy) | −19,026 | 0 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_161109171024831.xml…